Joseph J. Jennings, MD, and Cynthia L. Sears, MD, describe the systemic effects of H pylori infection and clinical approaches for treating the extragastric complications.
Elevated gastrin levels can be a sign of hypergastrinemia or gastrinoma. However, other factors may be the cause. Investigators sought to better understand the difference.
Investigators assessed clinical predictors and the timing associated with development of symptomatic gastroesophageal reflux disease following H pylori infection eradication.
Investigators assessed the safety and efficacy of two 1-week quadruple therapies given consecutively in patients with difficult-to-treat Helicobacter pylori infections.
Investigators evaluated the diagnostic accuracy of certain mucosal predictors of Helicobacter pylori status and aimed to validate a simple prediction model.
Investigators conducted a study to determine the relationship between gut microbiota and ghrelin concentrations among patients with positive Helicobacter pylori infection vs those with antigen-negative H pylori infection who received eradication therapy.
Researchers performed a network meta-analysis to compare the effectiveness of first-line regimens vs standard triple therapy in the treatment of H pylori infection.
Researchers compared the efficacy, adverse events, and compliance of HDDT vs BQT as first-line or rescue regimens and investigated factors contributing to H pylori eradication.